Activating dormant strongyloidiasis secondary to COVID-19 treatment
Crossref DOI link: https://doi.org/10.17352/2455-5282.000148
Published Online: 2022-02-01
Update policy: https://doi.org/10.17352/crossmark-policy
Alkaabba, Fahad
Li, Holman
Ibrahim, Farrah
License valid from 2022-02-01
